HER2/neu (E75) vaccine reduces breast cancer recurrence

By  

Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)

By Schilling G.   Bruweleit M.   Harbeck N.   Thomssen C.   Becker K.   Hoffmann R.   Villena C.   Schütte M.   Hossfeld D.   Bokemeyer C.   Wit M.  

Investigational New Drugs, Vol. 27, Iss. 2, 2009-04 ,pp. : 166-172

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer

By Ganesan Prasanth   Piha-Paul Sarina   Naing Aung   Falchook Gerald   Wheler Jennifer   Janku Filip   Zinner Ralph   Laday Shell   Kies Merrill   Tsimberidou Apostolia  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1505-1513

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer

By Ganesan Prasanth   Piha-Paul Sarina   Naing Aung   Falchook Gerald   Wheler Jennifer   Fu Siqing   Hong David   Kurzrock Razelle   Janku Filip   Laday Shell   Bedikian Agop   Kies Merrill   Wolff Robert   Tsimberidou Apostolia  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 279-286

Springer Publishing Company

Access to resources Recommend Favorite

Alexza Pharmaceuticals has announced that it has completed enrolment in its second phase III trial with loxapine

By  

Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite